Consistently, in the context of allergic asthma, EP2 activation has likewise been found to inhibit lung MC and eosinophil activation (34, 35), whereas EP4 activation reduces allergen-induced airway hyperresponsiveness (36). This evidence concerns the gene PTGER4 and airway hyperresponsiveness.